Identification of a Novel Mode of Complement Activation on Stimulated Platelets Mediated by Properdin and C3(H2O)
- 15 June 2013
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 190 (12), 6457-6467
- https://doi.org/10.4049/jimmunol.1300610
Abstract
Elevated numbers of activated platelets circulate in patients with chronic inflammatory diseases, including atherosclerosis and coronary disease. Activated platelets can activate the complement system. Although complement activation is essential for immune responses and removal of spent cells from circulation, it also contributes to inflammation and thrombosis, especially in patients with defective complement regulation. Proinflammatory activated leukocytes, which interact directly with platelets in response to vascular injury, are among the main sources of properdin, a positive regulator of the alternative pathway. The role of properdin in complement activation on stimulated platelets is unknown. Our data show that physiological forms of human properdin bind directly to human platelets after activation by strong agonists in the absence of C3, and bind nonproportionally to surface CD62P expression. Activation of the alternative pathway on activated platelets occurs when properdin is on the surface and recruits C3b or C3(H2O) to form C3b,Bb or a novel cell-bound C3 convertase [C3(H2O),Bb], which normally is present only in the fluid phase. Alternatively, properdin can be recruited by C3(H2O) on the platelet surface, promoting complement activation. Inhibition of factor H–mediated cell surface complement regulation significantly increases complement deposition on activated platelets with surface properdin. Finally, properdin released by activated neutrophils binds to activated platelets. Altogether, these data suggest novel molecular mechanisms for alternative pathway activation on stimulated platelets that may contribute to localization of inflammation at sites of vascular injury and thrombosis.Keywords
This publication has 79 references indexed in Scilit:
- Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injuryKidney International, 2011
- Native Properdin Binds to Chlamydia pneumoniae and Promotes Complement ActivationInfection and Immunity, 2011
- Identification of Tubular Heparan Sulfate as a Docking Platform for the Alternative Complement Component Properdin in Proteinuric Renal DiseaseJournal of Biological Chemistry, 2011
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Complement activation on platelets: Implications for vascular inflammation and thrombosisMolecular Immunology, 2010
- Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complementImmunobiology, 2010
- Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodiesLupus, 2009
- Complement activation triggered by chondroitin sulfate released by thrombin receptor‐activated plateletsJournal of Thrombosis and Haemostasis, 2008
- The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosisProceedings of the National Academy of Sciences of the United States of America, 2008
- Factor H–mediated cell surface protection from complement is critical for the survival of PNH erythrocytesBlood, 2007